Glutamic Acid decarboxylase therapy for recent-onset type 1 diabetes: are we at the end or the beginning of finding a cure?
作者信息
Fleming G Alexander, Klonoff David C
出版信息
J Diabetes Sci Technol. 2009 Mar 1;3(2):215-8. doi: 10.1177/193229680900300201.
Abstract
摘要
相似文献
1
Glutamic Acid decarboxylase therapy for recent-onset type 1 diabetes: are we at the end or the beginning of finding a cure?谷氨酸脱羧酶治疗新发1型糖尿病：我们是处于找到治愈方法的终点还是起点？
J Diabetes Sci Technol. 2009 Mar 1;3(2):215-8. doi: 10.1177/193229680900300201.
2
Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes.
J Endocrinol Invest. 1994 Jul-Aug;17(7):581-4. doi: 10.1007/BF03347753.
3
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.GAD65 抗原治疗新诊断的 1 型糖尿病。
N Engl J Med. 2012 Feb 2;366(5):433-42. doi: 10.1056/NEJMoa1107096.
4
Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus.
Lancet. 1994 Jun 25;343(8913):1607-8. doi: 10.1016/s0140-6736(94)93061-9.
5
Immunotherapy on trial for new-onset type 1 diabetes.免疫疗法用于新发1型糖尿病的试验。
N Engl J Med. 2008 Oct 30;359(18):1956-8. doi: 10.1056/NEJMe0807425. Epub 2008 Oct 8.
6
Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial.两剂谷氨酸脱羧酶铝佐剂疫苗治疗伴多种胰岛自身抗体的儿童发生 1 型糖尿病的安全性和有效性：一项随机临床试验。
Pediatr Diabetes. 2018 May;19(3):410-419. doi: 10.1111/pedi.12611. Epub 2017 Nov 24.
7
HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.HLA - DR53分子将谷氨酸脱羧酶肽呈递给一名I型糖尿病患者的T细胞：三分子HLA - 肽/T细胞受体复合物的特性
Diabetologia. 2001 Jan;44(1):70-80. doi: 10.1007/s001250051582.
8
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.对谷氨酸脱羧酶的免疫反应与非肥胖糖尿病小鼠的胰岛炎相关。
J Endocrinol Invest. 1994 Jul-Aug;17(7):586-93. doi: 10.1007/BF03347755.
9
T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects.新发胰岛素依赖型糖尿病（IDDM）患者、发病后IDDM患者及对照受试者中T细胞对与柯萨奇病毒蛋白共有GAD65肽序列的反应性。
Diabetologia. 1997 Mar;40(3):332-8. doi: 10.1007/s001250050683.
10
Effect of gamma aminobutyric acid (GABA) or GABA with glutamic acid decarboxylase (GAD) on the progression of type 1 diabetes mellitus in children: Trial design and methodology.γ-氨基丁酸（GABA）或 GABA 联合谷氨酸脱羧酶（GAD）对儿童 1 型糖尿病进展的影响：试验设计与方法。
Contemp Clin Trials. 2019 Jul;82:93-100. doi: 10.1016/j.cct.2019.06.007. Epub 2019 Jun 20.
引用本文的文献
1
Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development.解决1型糖尿病未满足的医疗需求：对正在研发的药物的综述
Curr Diabetes Rev. 2017;13(3):300-314. doi: 10.2174/1573399812666160413115655.
本文引用的文献
1
The role of immunomodulation therapy in autoimmune diabetes.免疫调节疗法在自身免疫性糖尿病中的作用。
J Diabetes Sci Technol. 2009 Mar 1;3(2):320-30. doi: 10.1177/193229680900300213.
2
Immunotherapy on trial for new-onset type 1 diabetes.免疫疗法用于新发1型糖尿病的试验。
N Engl J Med. 2008 Oct 30;359(18):1956-8. doi: 10.1056/NEJMe0807425. Epub 2008 Oct 8.
3
GAD treatment and insulin secretion in recent-onset type 1 diabetes.近期发病的1型糖尿病中的广泛性焦虑症治疗与胰岛素分泌
N Engl J Med. 2008 Oct 30;359(18):1909-20. doi: 10.1056/NEJMoa0804328. Epub 2008 Oct 8.
Zotero 插件